• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前代谢肿瘤体积和总病变糖酵解对上皮性卵巢癌患者的预后价值。

Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.

机构信息

Department of Obstetrics and Gynecology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

出版信息

Ann Surg Oncol. 2012 Jun;19(6):1966-72. doi: 10.1245/s10434-011-2153-x. Epub 2011 Nov 29.

DOI:10.1245/s10434-011-2153-x
PMID:22124757
Abstract

PURPOSE

Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) are measures of metabolic activity of tumors determined by fluorine-18 fluorodeoxyglucose ([(18)F]FDG) uptake on PET/CT images. The purpose of this study was to investigate the relationship between functional tumor parameters (MTV and TLG) and clinical outcomes in patients with epithelial ovarian cancer (EOC).

METHODS

Fifty-five patients with EOC who had undergone [(18)F]FDG PET/CT before surgical staging were included in this retrospectively study. For each patient, we determined the highest (SUV(max) and SUV(avg)), the cumulative TLG, and the sum of all MTV, and compared their predictive value of recurrence and the effects of pretreatment functional tumor activity on progression-free interval (PFI).

RESULTS

The median duration of PFI was 11 (range 3-43) months, and 20 patients (36.4%) experienced recurrence. Poor outcome was associated with higher values for both the MTV (P = 0.022, hazard ratio 5.571, 95% confidence interval 1.279-24.272) and the TLG (P = 0.037, hazard ratio 2.967, 95% confidence interval 1.065-8.265). The Kaplan-Meier survival graphs showed a significant difference in PFI between the groups categorized by MTV and TLG, respectively (P = 0.01 for MTV, P = 0.0287 for TLG, log rank test).

CONCLUSIONS

Pretreatment metabolic parameters such as MTV and TLG showed statistically significant association with recurrence in patients with EOC. These values can be useful quantitative criteria for disease prognostication in patients with EOC before treatment.

摘要

目的

代谢肿瘤体积(MTV)和总肿瘤糖酵解(TLG)是通过氟-18 氟代脱氧葡萄糖 ([(18)F]FDG) 在 PET/CT 图像上摄取来衡量肿瘤代谢活性的指标。本研究旨在探讨上皮性卵巢癌(EOC)患者功能肿瘤参数(MTV 和 TLG)与临床结局之间的关系。

方法

本回顾性研究纳入了 55 例在手术分期前接受 [(18)F]FDG PET/CT 的 EOC 患者。对于每位患者,我们确定了最高(SUV(max) 和 SUV(avg))、累积 TLG 和所有 MTV 的总和,并比较了它们对复发的预测价值以及治疗前功能肿瘤活性对无进展生存期(PFI)的影响。

结果

PFI 的中位时间为 11 个月(范围 3-43 个月),20 例患者(36.4%)复发。不良结局与 MTV(P = 0.022,风险比 5.571,95%置信区间 1.279-24.272)和 TLG(P = 0.037,风险比 2.967,95%置信区间 1.065-8.265)值均较高有关。Kaplan-Meier 生存曲线显示,根据 MTV 和 TLG 分类的 PFI 之间存在显著差异(MTV 组 P = 0.01,TLG 组 P = 0.0287,对数秩检验)。

结论

治疗前代谢参数如 MTV 和 TLG 与 EOC 患者的复发具有统计学显著相关性。这些值可作为治疗前 EOC 患者疾病预后的有用定量标准。

相似文献

1
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.术前代谢肿瘤体积和总病变糖酵解对上皮性卵巢癌患者的预后价值。
Ann Surg Oncol. 2012 Jun;19(6):1966-72. doi: 10.1245/s10434-011-2153-x. Epub 2011 Nov 29.
2
Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.18F-FDG PET/CT 定量代谢体积测量在 IV 期非手术小细胞肺癌中的预后价值。
Acad Radiol. 2012 Jan;19(1):69-77. doi: 10.1016/j.acra.2011.08.020.
3
Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.下咽鳞状细胞癌治疗前代谢肿瘤体积和总病变糖酵解的临床意义
J Surg Oncol. 2014 Dec;110(7):869-75. doi: 10.1002/jso.23729. Epub 2014 Aug 2.
4
Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.使用术前18F-FDG PET/CT测量的代谢肿瘤体积和总病灶糖酵解可预测子宫内膜癌的复发。
BJOG. 2014 Aug;121(9):1097-106; discussion 1106. doi: 10.1111/1471-0528.12543. Epub 2014 Jan 8.
5
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.(18)F-FDG PET 代谢肿瘤负荷对非小细胞肺癌手术患者的预后价值。
Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.
6
Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.上皮性卵巢癌三级细胞减灭术的价值:一项国际多中心评估。
Ann Surg Oncol. 2013 Apr;20(4):1348-54. doi: 10.1245/s10434-012-2673-z. Epub 2012 Oct 2.
7
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.术前 ¹⁸F-FDG PET/CT 代谢肿瘤体积和总病变糖酵解对胰腺癌患者的预后价值。
J Nucl Med. 2014 Jun;55(6):898-904. doi: 10.2967/jnumed.113.131847. Epub 2014 Apr 7.
8
Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.治疗前 FDG PET/CT 全身总病变糖酵解对非小细胞肺癌的预后价值。
Radiology. 2012 Aug;264(2):559-66. doi: 10.1148/radiol.12111148. Epub 2012 Jun 12.
9
Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.18F-氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在预测不可切除转移性肝癌患者行钇-90 放射性栓塞治疗后的生存预后中的价值。
J Vasc Interv Radiol. 2012 Jul;23(7):943-8. doi: 10.1016/j.jvir.2012.04.010. Epub 2012 May 19.
10
Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue.[18F]-氟脱氧葡萄糖 PET/CT 测量的代谢肿瘤体积与舌口腔鳞状细胞癌的隐匿性转移相关。
Ann Surg Oncol. 2009 Nov;16(11):3111-7. doi: 10.1245/s10434-009-0621-3. Epub 2009 Jul 16.

引用本文的文献

1
Exploring currently available fibroblast activation protein targeting molecules in adrenocortical carcinoma: Navigating theranostic pathways.探索肾上腺皮质癌中目前可用的成纤维细胞活化蛋白靶向分子:探寻诊疗途径。
Eur J Nucl Med Mol Imaging. 2025 Mar 22. doi: 10.1007/s00259-025-07203-4.
2
Prognostic Value of Pretreatment F-FDG-PET/CT Metabolic Parameters in Advanced High-Grade Serous Ovarian Cancer.治疗前F-FDG-PET/CT代谢参数在晚期高级别浆液性卵巢癌中的预后价值
Cancers (Basel). 2025 Feb 19;17(4):698. doi: 10.3390/cancers17040698.
3
Are MTV and TLG Accurate for Quantifying the Intensity of Brown Adipose Tissue Activation?
MTV和TLG在量化棕色脂肪组织激活强度方面准确吗?
Biomedicines. 2024 Jan 11;12(1):151. doi: 10.3390/biomedicines12010151.
4
Prognostic F-FDG Radiomic Features in Advanced High-Grade Serous Ovarian Cancer.晚期高级别浆液性卵巢癌的预后F-FDG放射组学特征
Diagnostics (Basel). 2023 Nov 7;13(22):3394. doi: 10.3390/diagnostics13223394.
5
Application of preoperative fluorodeoxyglucose-PET/CT parameters for predicting prognosis of high-grade neuroendocrine cervical cancer.术前氟脱氧葡萄糖-PET/CT参数在预测高级别宫颈神经内分泌癌预后中的应用
Nucl Med Commun. 2023 Nov 1;44(11):1005-1010. doi: 10.1097/MNM.0000000000001741. Epub 2023 Aug 14.
6
Predictive value of PET metabolic parameters for occult lymph node metastases in PET/CT defined node-negative patients with advanced epithelial ovarian cancer.PET 代谢参数对 PET/CT 定义的晚期上皮性卵巢癌淋巴结阴性患者隐匿性淋巴结转移的预测价值。
Sci Rep. 2023 Jun 9;13(1):9439. doi: 10.1038/s41598-023-36640-0.
7
Predictive value of F-FDG PET/CT for evaluating the response to hypofractionated radiotherapy combined with PD-1 blockade in non-small cell lung cancer.18F-FDG PET/CT 预测 NSCLC 患者接受 PD-1 单抗联合低分割放疗的疗效
Front Immunol. 2023 Feb 13;14:1034416. doi: 10.3389/fimmu.2023.1034416. eCollection 2023.
8
The reduction of F-FDG uptake ability of tumor tissue after neoadjuvant chemoradiotherapy in locally advanced rectal cancer can effectively reflect the degree of tumor regression.局部晚期直肠癌新辅助放化疗后肿瘤组织F-FDG摄取能力的降低可有效反映肿瘤退缩程度。
Front Oncol. 2022 Dec 22;12:1037783. doi: 10.3389/fonc.2022.1037783. eCollection 2022.
9
Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.代谢活性取决于宫颈癌淋巴结受累程度,决定其生存情况。
BMC Cancer. 2022 Jul 23;22(1):810. doi: 10.1186/s12885-022-09785-w.
10
A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies.核医学方法在妇科恶性肿瘤诊断与治疗中的综述
Cancers (Basel). 2022 Mar 31;14(7):1779. doi: 10.3390/cancers14071779.